Expression of lymphotoxin-beta (LT-β) in chronic inflammatory conditions

Journal of Pathology

Volumn 199, Issue 1, 2003, Pages 115-121

  Agyekum, Sarah ^a   Church, Alison ^a   Sohail, Muhammed ^a   Krausz, Thomas ^a   Van Noorden, Susan ^a   Polak, Julia ^a   Cohen, Jonathan ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Inflammation; Inflammatory bowel disease; Lymphotoxin; Sarcoidosis; Tuberculosis; Tumour necrosis factor

Indexed keywords

LYMPHOTOXIN; POLYCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CELL TYPE; CHRONIC INFLAMMATION; CONTROLLED STUDY; ENTERITIS; EPITHELIOID CELL; GIANT CELL; GRANULOMA; HISTIOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE; LYMPH NODE; LYMPHOCYTE SUBPOPULATION; LYMPHOID CELL; MALE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SARCOIDOSIS; SPLEEN; T LYMPHOCYTE; TONSIL; TUBERCULOSIS;

ADULT; AGED; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; DUODENUM; FEMALE; FLOW CYTOMETRY; HUMANS; ILEUM; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; LYMPH NODES; LYMPHOTOXIN-ALPHA; LYMPHOTOXIN-BETA; MALE; MEMBRANE PROTEINS; MIDDLE AGED; RECOMBINANT PROTEINS; SARCOIDOSIS; TUBERCULOSIS;

EID: 0037218879     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1249     Document Type: Article

References (22)

1. Warzocha K, Bienvenu J, Coiffier B, Salles G. Mechanisms of action of the tumour necrosis factor and lymphotoxin ligand-receptor system. Eur Cytok Netw 1994; 5: 83-96.
2. Browning JL, Androlewicz MJ, Ware CF. Lymphotoxin and an associated 33 kDa glycoprotein are expressed on the surface of an activated human T cell hybridoma. J Immunol 1991; 147: 1230-1237.
3. Androlewicz MJ, Browning JL, Ware CF. Lymphotoxin is expressed as a heteromeric complex with a distinct 33-kDa glycoprotein on the surface of an activated T cell hybridoma. J Biol Chem 1992; 267: 2542-2547.
4. Browning JL, Ngam-ek A, Lawton P, et al. Lymphotoxin β, a novel member of the TNF family that forms a heteromeric complex with LT on the cell surface. Cell 1993; 72: 847-856.
5. Schoenfeld HJ, Poeschle B, Frey JR, et al. Efficient purification of recombinant human tumour necrosis factor β from Escherichia coli yields biologically active protein with a trimeric structure that binds to both tumour necrosis factor receptors. J Biol Chem 1991; 266: 3863-3869.
6. Browning JL, Dougas I, Ngam-ek A, et al. Characterisation of surface lymphotoxin forms. J Immunol 1995; 154: 33-46.
7. Crowe PD, VanArsdale TL, Walter B, et al. A lymphotoxin-β specific receptor. Science 1994; 264: 707-710.
8. De Togni P, Goellner J, Ruddle NH, et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 1994; 264: 703-707.
9. Banks TA, Rouse BT, Kerley MK, et al. Lymphotoxin-α-deficient mice. J Immunol 1995; 155: 1685-1693.
10. Matsumoto M, Mariathasan S, Nahm M, Baranyay F, Peschon JJ, Chaplin D. Role of lymphotoxin and the type 1 TNF receptor in the formation of germinal centres. Science 1996; 271: 1289-1291.
11. Rennert PD, Browning JL, Mebius R, Mackay F, Hochman PS. Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs. J Exp Med 1996; 184: 1999-2006.
12. Koni PA, Sacca R, Lawton P, Browning JL, Ruddle N, Flavell RA. Distinct roles in lymphoid organogenesis for lymphotoxins α and β revealed in lymphotoxin β-deficient mice. Immunity 1997; 6: 491-500.
13. Ware CF, Crowe PD, Grayson MH, Androlewicz MJ, Browning JL. Expression of surface lymphotoxin and tumour necrosis factor on activated T, B and natural killer cells. J Immunol 1992; 149: 3881-3888.
14. Kratz A, Campos-Neto A, Hanson MS, Ruddle NH. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J Exp Med 1996; 183: 1461-1472.
15. Picarella DE, Kratz A, Li C-B, Ruddle NH, Flavell RA. Insulitis in transgenic mice expressing TNF-β (lymphotoxin) in the pancreas. Proc Natl Acad Sci U S A 1992; 89: 10 036-10 040.
16. Kratz A, Campos-Neto A, Hanson MS, Ruddle NH. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J Exp Med 1996; 183: 1461-1472.
17. Van Dullemen HM, Van Deventer SJH, Hommes DW, et al. Treatment of Crohn's disease with anti-tumour necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995; 109: 129-135.
18. Mackay F, Browning JL, Lawton P, et al. Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis. Gastroenterology 1998; 115: 1464-1475.
19. Bergeron A, Bonay M, Kambouchner M, et al. Cytokine patterns in tuberculous and sarcoid granulomas: correlations with histopathologic features of the granulomatous response. J Immunol 1997; 159: 3034-3043.
20. Boussaud V, Soler P, Moreau J, Goodwin RG, Hance AJ. Expression of three members of the TNF-R family of receptors (4-1BB, lymphotoxin-beta receptor, and Fas) in human lung. Eur Respir J 1998; 12: 926-931.
21. Murphy M, Walter BN, Pike-Nobile L, et al. Expression of the lymphotoxin β receptor on follicular stromal cells in human lymphoid tissues. Cell Death Differentiation 1998; 5: 497-505.
22. Mebius RE, Streeter PR, Michie S, Butcher EC, Weissman IL. A developmental switch in lymphocyte homing receptor and endothelial vascular addressin expression regulates lymphocyte homing and permits CD4 + CD3- cells to colonize lymph nodes. Proc Natl Acad Sci U S A 1996; 96: 11 019-11 024.